Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.
about
Shortcomings in the current treatment of epilepsyPhenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data reviewCarbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data reviewTopiramate versus carbamazepine monotherapy for epilepsy: an individual participant data reviewAntiepileptic drug monotherapy for epilepsy: a network meta-analysisCarbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data reviewTreatment for epilepsy in pregnancy: congenital malformation outcomes in the childPreconception counselling for women with epilepsy to reduce adverse pregnancy outcomePreconception counselling for women with epilepsyPhenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizuresPreconception counselling for women with epilepsy to reduce adverse pregnancy outcomeIntrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control studyCognitive function at 3 years of age after fetal exposure to antiepileptic drugsThe role of lamotrigine in the management of bipolar disorderThe SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature ReviewManagement of epilepsy during pregnancy: an updatePsychopharmacoteratophobia: Excessive fear of malformation associated with prescribing psychotropic drugs during pregnancy: An Indian perspectiveAdvantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy RegistryMaternal and Fetal Outcomes After Lamotrigine Use in Pregnancy: A Retrospective Analysis from an Urban Maternal Mental Health Centre in New ZealandEpilepsy during pregnancy: focus on management strategiesEnsuring the safe and effective use of medications during pregnancy: planning and prevention through preconception careAnticonvulsant Effect of Guaifenesin against Pentylenetetrazol-Induced Seizure in MiceCongenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort StudyLamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.EURAP outcomes for seizure control during pregnancy: useful and encouraging data.Time to 12-month remission and treatment failure for generalised and unclassified epilepsy.Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled studyPrenatal effects of antiepileptic drugs.Teratogenic Effects of Carbamazepine in MiceComparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis.Fetal valproate syndrome in a 2-month-old male infantAntiepileptic drugs in women with epilepsy during pregnancyNew generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsantsPharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsyPrevalence of treated epilepsy in Korea based on national health insurance dataTopiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.
P2860
Q22305925-1CCFE0CE-D628-4F82-8899-F63FF7FC5BEAQ24185852-D472E60D-9BFB-4966-BF6C-5D25D670AC37Q24186327-74079A92-62F1-488B-86FC-5C1C2662E9BCQ24186683-B51760BD-A48E-4D98-BB89-DEB05C5AB829Q24187678-C8A676C1-4F1D-4454-B082-34E9123985E6Q24187872-721879B0-5A13-4F40-8D0D-1F0CA8423DAEQ24197881-6417E496-DC0C-4984-80BB-FFB8893FD5DAQ24198152-38B71CCE-FE17-4D74-8506-E2678F8F7EC8Q24198815-B8424C24-3AA1-4AE8-93F0-5D81370E1BB9Q24200276-024A1D14-561C-4567-AB1B-D07B960ED7B9Q24242734-BEF1B555-A1EB-498E-BCE4-5FF0EB112916Q24631492-E8E6DCF9-95CE-4F5B-90B5-0CBE40301413Q24642570-895A0951-8BF5-43A0-BF85-C9D2291EA31CQ24658110-C67C7B77-D9D0-494E-8745-49C4BBC504F7Q24676550-BBD07593-24C2-4BEF-875F-D78C1030CE97Q26741366-7F9BACD4-3603-4D92-AF84-F9FE5690D78FQ26752470-5F879E79-68D9-455D-BAA0-1F36FCECF229Q26776321-41101606-21AB-4115-A6C5-7C59640CC56AQ26858860-5CAC17AC-C9E2-4903-AA76-1C8F702E6334Q28079787-71990C68-A2D9-4EB3-8BA0-5C6BB30C6D97Q28080299-506D261B-AEDD-479B-9DB1-C49C8EFE4D76Q28199588-F643126B-3332-4707-9BEB-AC4944DA1A08Q28293894-7642B1D4-3715-45FE-ABDC-D2B75F1CC729Q28546202-1726780A-AF0B-43E8-A286-9AE324086145Q31142199-F93EA10B-3E71-4242-83DC-2B57084A9A14Q31147165-0C2145C8-D4C1-4284-9768-DE25516027FDQ31166723-0509D57F-9237-4F07-820A-715A0100772BQ33270669-ED949399-042E-4F04-A6CA-7CFCA4D7D852Q33658630-3C6FFA56-8457-48B7-8E58-E8DA7FC2278EQ33665151-E1D137F9-0B0B-412F-B776-A9E2242ACBDEQ33719069-51C9196D-51EC-4A63-8DB4-8D5203008054Q33795502-1AFC66EC-F581-4128-B4E4-3F25B28AA488Q33861432-19EDC859-2112-4570-BAC7-6A2EE6DECE71Q33918039-1CF4F3CF-A509-4734-B73C-763AFBEDB769Q33949402-42FEB039-6281-42CF-9575-ED8B51DAE345Q33949491-AA936A2D-DE64-4967-98A0-B8670EA1E7F8Q34147151-C80994C2-AD36-4190-BFB7-F32907FFEB27Q34169804-95D9BF40-8267-4C01-BD0D-B5F8FF6E3F95Q34179734-C1D78F8E-2696-4835-961E-C5FE110D75D3Q34180705-B18F6648-4E48-45E6-9A3C-805BD308D205
P2860
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Malformation risks of antiepil ...... ilepsy and Pregnancy Register.
@ast
Malformation risks of antiepil ...... ilepsy and Pregnancy Register.
@en
type
label
Malformation risks of antiepil ...... ilepsy and Pregnancy Register.
@ast
Malformation risks of antiepil ...... ilepsy and Pregnancy Register.
@en
prefLabel
Malformation risks of antiepil ...... ilepsy and Pregnancy Register.
@ast
Malformation risks of antiepil ...... ilepsy and Pregnancy Register.
@en
P2093
P2860
P356
P1476
Malformation risks of antiepil ...... ilepsy and Pregnancy Register.
@en
P2093
I Robertson
P J Morrison
R C McGivern
P2860
P304
P356
10.1136/JNNP.2005.074203
P407
P577
2005-09-12T00:00:00Z